Cytomegalovirus Assay Demand Spurred by Increasing Cytomegalovirus Infection Cases: Says Fact.MR

Fact.MR, a global research firm, in its latest research on the cytomegalovirus assay market indicated that the market will exhibit a steady CAGR in 2021. Some of the key factors influencing the growth of cytomegalovirus assay are high prevalence of chronic ailments such as diabetes and cancer, increasing patient awareness regarding CMV, rising incidences of congenital CMV, rise in r&d initiatives, introduction of HTS (high-throughput screening) for vaccination and drug discovery, and growth in genomic technology.

Several research laboratories and institutes are focusing on CMV tests for the cytomegalovirus diagnosis via diverse technologies. Approach by physicians and modulation of a unique technology ensures enhanced functional ability of this test. New expansion in CMV vaccine and pharmological therapy approaches ensure to image the function of immune system at the molecular and cellular level. This is optimistically impacting early treatment and diagnosis of ailments.” states Fact.MR.

High Prevalence of Congenital CMV to Propel Cytomegalovirus Assay

As per the CDC (Centers for Disease Control and Prevention), in the U.S. around 50% of adults are impacted with CMV through the age of 40. About 90% of newborns with CMV have no symptoms, however 10% to 15% develop hearing loss, generally amid their first six months of life. The rigorousness ranges from minor to total hearing loss. In spite of the advancement in infection rates, CMV testing is further increasing all over the globe. Rising neonatal births rates, rising number of patients with cancer, and swiftly increasing awareness about vaccines and therapeutics shall encourage the cytomegalovirus (CMV) assay market. 

Request Sample Report-

ELISA to Gain Traction Among Other Test Type

Antigenemia assay contributed the biggest share which relied on the usage of monoclonal antibodies that distinguish the viral pp65 antigen. On the other hand, various CMV assay are used for the discovery of CMV IgG antibodies for instance ELISA (enzyme-linked immunosorbent assay), anti-complement immunofluorescence, radioimmunoassay and indirect hemagglutination. Amid all enzyme-linked immunosorbent assays (ELISAs) is extensively utilized and is relied on crude viral preparations.

FactMR’s study also reveal that Congenital CMV infection is been recognized as a key cause of brain disease and congenital infection in children in U.S. Around 20,000 to 40,000 infants are born every year with congenital CMV infection in the U.S.. 

The US Cytomegalovirus Assay Market will Remain Lucrative

Rise in funding for the expansion of health care and research infrastructure is putting The US in a bright spot. Growing incidences of ailments such as HIV and cancer and early treatment and phase diagnosis of the diseases are boosting the biotechnology and research sector.

The UK is a key region of the cytomegalovirus assay market owing to favourable government policies concerning the expansion of diagnostic laboratories and health care infrastructure. 

The market in Japan, China and India shall grow at a higher growth pace in 2021 & beyond owing to increasing birth rates, changing lifestyle, and growing awareness amid patients regading diseases such as HIV and cancer, and increasing per capita expenditure. Furthermore, the economic growth in China and India is amplifying health care infrastructure and encouraging the growth of biotech labs and pharmaceutical companies.

Do Enquiry Before Buying

Introducing Highly Advanced Products Remains Prime Focal Area: Fact.MR Survey

Cytomegalovirus assay market growth is spurred by the existence of several key players. Fact.MR’s survey with thought leaders revealed that increasing research & development exercises will remain a prominent strategy for market players in 2021 & beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. Some of the players profiled in the report are Qiagen, Merck KGaA, Abcam plc, DiaSorin Molecular LLC, BioVision Inc, and Norgen Biotek Corp. The updated edition also offers a detailed analysis of the COVID-19 impact on this market.

Explore Fact.MR’s Healthcare Reports Delve into Fact.MR’s extensive study on the large macrolide drugs market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities. The global neonatal monitoring test market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets. Fact.MR’s global Helicobacter Pylori (H-Pylori) non-invasive testing market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583


Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai, United Arab Emirates

Back to news